Natera, INC Form 4 insider transactions

Natera, Inc. Director Brinkley Ruth Williams was granted 2,143 restricted stock units, increasing her beneficial ownership to 5,107 shares.

Natera, Inc. Director Herm Rosenman was granted 2,414 restricted stock units (RSUs) on June 27, 2025, as part of his compensation, aligning his interests with long-term shareholder value.

Natera, Inc. Director Gail Boxer Marcus acquired 2,414 Restricted Stock Units (RSUs) as part of her compensation, aligning her interests with long-term shareholder value.

Natera, Inc. Director Roelof Botha was granted 2,414 Restricted Stock Units (RSUs) on June 27, 2025, aligning his interests with long-term shareholder value.

Natera, Inc. Director Monica Bertagnolli acquired 2,143 restricted stock units, increasing her direct beneficial ownership to 5,020 shares.

Natera, Inc. Director Roy D. Baynes was granted 2,143 restricted stock units, increasing his direct beneficial ownership to 18,158 shares.

Matthew Rabinowitz, Executive Chairman of Natera, Inc., reported the sale of 44,000 shares of common stock through a Rule 10b5-1 trading plan, with transactions occurring between May 15 and June 13, 2025.

Natera, Inc. Co-Founder and Director Jonathan Sheena reported the sale of 6,070 shares of common stock for approximately $1 million through pre-arranged trading plans.

Natera, Inc. Director Gail Boxer Marcus executed a pre-planned sale of 4,000 shares of common stock totaling approximately $650,000 on June 10, 2025, pursuant to a Rule 10b5-1 trading plan.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 3,000 shares of common stock on June 2, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Natera, Inc. CEO and President Steven Leonard Chapman sold a total of 6,111 shares of common stock on June 2, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on May 9 and May 12, 2025, under pre-arranged Rule 10b5-1 trading plans.

Natera's CEO, Steven Leonard Chapman, sold a portion of his common stock holdings on May 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., executed multiple sales of common stock on May 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Marcus Gail Boxer reported the sale of Natera, Inc. (NTRA) common stock on May 1, 2025, according to a Form 4 filing with the SEC.

Jonathan Sheena, co-founder of Natera, Inc., sold 439 shares of common stock on April 28, 2025, to satisfy tax withholding obligations related to vesting RSUs.

Matthew Rabinowitz, Executive Chairman of Natera, Inc., sold 1,718 shares of common stock on April 28, 2025, to satisfy tax withholding obligations related to vesting RSUs.

Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc., reports the sale of 1,993 shares of common stock to cover tax obligations related to RSU vesting.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 2,206 shares of common stock on April 28, 2025, to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 1,709 shares of common stock on April 28, 2025, to satisfy tax withholding obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, sold 6,203 shares of common stock on April 28, 2025, to satisfy tax withholding obligations related to vesting RSUs.

Natera's CFO, Michael Brophy, sold shares of common stock to cover tax obligations related to vesting RSUs and under a pre-arranged 10b5-1 trading plan.

Director Herm Rosenman acquired 164 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.

Director James Healy of Natera, Inc. receives fully vested restricted stock units (RSUs) in lieu of quarterly retainer fees.

Director Roelof Botha acquired 185 shares of Natera, Inc. common stock through the issuance of RSUs in lieu of quarterly retainer fees.

Director Roy D. Baynes acquired 116 shares of Natera, Inc. common stock through fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.

Natera's CFO, Michael Brophy, reported the sale of common stock and vesting of restricted stock units (RSUs) in a series of transactions from April 22 to April 24, 2025, according to a Form 4 filing with the SEC.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Natera's CEO, Steven Chapman, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

John Fesko, President and Chief Business Officer of Natera, Inc., sold shares of common stock on April 21, 2025, to satisfy tax withholding obligations related to vesting RSUs.